References
Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol 2012; 26: 3–11.
Kimball AB, Gladman D, Gelfand JM, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008; 58: 1031–42.
Kimball AB, Szapary P, Mrowietz U, et al. Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. J Am Acad Dermatol 2012; 67: 76–85.
Ahlehoff O, Skov L, Gislason G, et al. Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registries. PLoS One 2012; 7: e36342.
Parsi KK, Brezinski EA, Lin TC, Li CS, Armstrong AW. Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists. J Am Acad Dermatol 2012; 67: 357–62.
Manalo IF, Gilbert KE, Wu JJ. Survey of trends and gaps in dermatologists’ cardiovascular screening practices in psoriasis patients: areas still in need of improvement. J Am Acad Dermatol 2015; 73: 872–4.
Lee MK, Kim HS, Cho EB, Park EJ, Kim KH, Kim KJ. A study of awareness and screening behavior of cardiovascular risk factors in patients with psoriasis and dermatologists. Ann Dermatol 2015; 27: 59–65.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Raposo, I., Bettencourt, A., Selores, M. et al. Awareness and screening attitudes of Portuguese dermatologists on cardiovascular risk factors in psoriatic patients. Eur J Dermatol 27, 443–445 (2017). https://doi.org/10.1684/ejd.2017.3053
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2017.3053